Editorial: Cancer Research: Does It Deliver for the Patient? Phase I Study of Interleukin-2 Combined with Interferon-a and 5-fluorouracil in Patients with Metastatic Renal Cell Cancer. Effect of Liposome-muramyl Tripeptide Combined with Recombinant Canine Granulocyte Colony-stimulating Factor on Can